Mortality and cancer morbidity in a cohort of Canadian petroleum workers

Occupational and Environmental Medicine

Volumn 60, Issue 12, 2003, Pages 918-928

  Lewis, R J ^a   Schnatter, A R ^a   Drummond, I ^b   Murray, N ^b   Thompson, F S ^b   Katz, A M ^b   Jorgensen, G ^a   Nicolich, M J ^a   Dahlman, D ^b   Theriault G ^c  

^a EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^b Imperial Oil Ltd Resources Limited   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; FUEL; HYDROCARBON; HYDROGEN SULFIDE; PETROLEUM; SOLVENT;

ADULT; ARTICLE; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CATALYST; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GALLBLADDER CARCINOMA; HIGH RISK POPULATION; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; MORBIDITY; OCCUPATIONAL EXPOSURE; PETROCHEMICAL INDUSTRY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT;

ADULT; CANADA; CAUSE OF DEATH; COHORT STUDIES; EXTRACTION AND PROCESSING INDUSTRY; FEMALE; HUMANS; HYDROCARBONS; HYDROGEN SULFIDE; INCIDENCE; MALE; MORTALITY; NEOPLASMS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PETROLEUM; RISK ASSESSMENT; SEX DISTRIBUTION; TIME FACTORS;

EID: 0344234448     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.60.12.918     Document Type: Article

References (64)

1. Lewis RJ, Schnatter AR, Katz AM, et al. Updated mortality among diverse operating segments of a petroleum company. Occup Environ Med 2000;57:595-604.
2. Schnatter AR, Theriault G, Katz AM, et al. A retrospective mortality study within operating segments of a petroleum company. Am J Ind Med 1992;22:209-29.
3. Schnatter AR, Katz AM, Nicolich MJ, et al. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect 1993;101:85-99.
4. Chemical Manufacturers Association Epidemiology Task Group. Guidelines for good epidemiology practices for occupational and environmental epidemiologic research. J Occup Med 1991;33:1221-9.
5. Drummond I, Murray N, Armstrong TW, et al. Exposure assessment methods for a study of mortality and cancer morbidity in relation to specific petroleum industry exposures. Unpublished report, 2002.
6. International Agency for Research on Cancer (IARC), International Association of Cancer Registries. Multiple primaries. IARC International Report No. 94/003 Lyon, 1994.
7. Cunningham J, Hamkey B, Lyles B, et al. SEER program code manual, revised edn. Cancer Statistics Branch, National Cancer Institute, 1992.
8. Hanis NM, Stavraky KM, Fowler JL. Cancer mortality in oil refinery workers. J Occup Med 1979;21:167-74.
9. International Agency for Research on Cancer (IARC). Monograph on the evaluation of carcinogenic risks to humans: occupational exposures in petroleum refining, crude oil, and major petroleum fuels. IARC Monograph 1989;45:39-117.
10. Delzell E, Austin H, Cole P. Epidemiologic studies of the petroleum industry. Occup Med 1988;3:455-74.
11. Wong O, Raabe GK. Critical review of cancer epidemiology in petroleum industry employees, with a quantitative meta-analysis by cancer site. Am J Ind Med 1989;15:283-310.
12. Schnatter AR, Acquavella JF, Thompson FS, et al. An analysis of death ascertainment and follow-up through Statistics Canada's mortality data base system. Can J Public Health 1990;81:60-5.
13. Acquavella JF, Donaleski D, Hanis NM. An analysis of mortality follow-up through the national death index for a cohort of refinery and petrochemical workers. Am J Ind Med 1986;9:181-7.
14. Marsh GM, Ehland J, Park M, et al. OCMAP/PC: a user-oriented cohort mortality analysis program for the IBM PC. Am Stat 1986;40:308-9.
15. Haenszel W, Loveland D, Sirkin MG. Lung cancer mortality as related to residence and smoking histories. J Natl Cancer Inst 1962;28:947-1001.
16. SAS Institute Inc. SAS Technical Report P-243. SAS/STAT Software: The GENMOD procedure, release 6.09. Cary, NC: SAS Institute Inc., 1993.
17. Roth SH, Skrajny B, Reiffenstein RJ. Alteration of the morphology and neurochemistry of the developing mammalian nervous system by hydrogen sulphide. Clin Exp Pharmacol Physiol 1995;22:379-80.
18. Roth SH. Toxicological effects of hydrogen sulfide in mammalian brain. Environ Epidemiol Toxicol 1999;1:241-8.
19. Kilbum KH. Function testing for chemical brain damage: a review. Arch Environ Health 2001;56:132-7.
20. United States Environmental Protection Agency. Health assessment document for hydrogen sulfide. EPA/600/8-86/026F. Washington, DC: Office of Research and Development, 1993.
21. Legator MS, Singleton CR, Morris DL, et al. Health effects from chronic low level exposure to hydrogen sulfide. Arch Environ Health 2001;56:123-31.
22. Canadian Council of Cancer Registries, Health and Welfare Canada, Statistics Canada. The making of the Canadian Cancer Registry: cancer incidence in Canada and its regions, 1969 to 1988. Ottawa, 1993.
23. Christie D, Robinson K, Gordon I, et al. A prospective study in the Australian petroleum industry. II. Incidence of cancer. Br J Ind Med 1991;48:511-14.
24. Jarvholm B, Mellblom B, Norrman R, et al. Cancer incidence of workers in the Swedish petroleum. Occup Environ Med 1997;54:686-91.
25. Pukkala E. Cancer incidence among Finnish oil refinery workers, 1971-1994. J Occup Environ Med 1998;40:675-9.
26. Huebner WW, Chen VW, Friedlander BR, et al. Incidence of lymphohaematopoietic malignancies in a petrochemical industry cohort: 1983-94 follow up. Occup Environ Med 2000;57:605-14.
27. Fox AJ, Collier PF. Low mortality rates in industrial cohort studies due to selection for work and survival in the industry. Br J Prev Soc Med 1976;30:225-30.
28. Monson RR. Observations on the healthy worker effect. J Occup Med 1986;28:425-33.
29. Gennaro V, Ceppi M, Boffetta P, et al. Pleural mesothelioma and asbestos among Italian oil refinery workers. Scand J Work Environ Health 1994;20:213-15.
30. Kaplan SD. Update of a mortality study of workers in petroleum refineries. J Occup Med 1986;28:514-16.
31. Tsai SP, Waddell LC, Gilstrap EL, et al. Mortality among maintenance employees potentially exposed to asbestos in a refinery and petrochemical plant. Am J Ind Med 1996;29:89-98.
32. Honda Y, Delzell E, Cole P. An updated study of morality among workers at a petroleum manufacturing plant. J Occup Environ Med 1995;37:194-200.
33. Huebner WW, Schnatter AR, Nicolich MJ, et al. Mortality experience of a young petrochemical industry cohort: 1979-1992 follow-up study of US-based employees. J Occup Environ Med 1997;39:970-82.
34. Satin KD, Wong O, Yuan LA, et al. A 50-year mortality follow-up of a large cohort of oil refinery workers in Texas. J Occup Environ Med 1996;38:492-506.
35. Tsai SP, Gilstrap EL, Colangelo TA, et al. A mortality study of oil refinery and petrochemical employees. J Occup Environ Med 1997;39:448-54.
36. Divine BJ, Hartman CM, Wendt JK. Update of the Texaco mortality study 1947-93: Part II. Analysis of specific causes of death for white men employed in refining, research, and petrochemicals. Occup Environ Med 1999;56:174-80.
37. Wong O, Raabe GK. Cell-type-specific leukemia analyses in a combined cohort of more than 208,000 petroleum workers in the United States and the United Kingdom, 1937-1989. Regul Toxicol Pharmacol 1995;21:307-21.
38. Schnatter AR, Armstrong TW, Nicolich MJ, et al. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med 1996;53:773-81.
39. Shallenberger LG, Acquavella JF, Donaleski D. An updated mortality study of workers in three major United States refineries and chemical plants. Br J Ind Med 1992;49:345-54.
40. Siemiatycki J, Dewar R, Nadon L, et al. Associations between several sites of cancer and twelve petroleum-derived liquids. Results from a case-referent study in Montreal. Scand J Work Environ Health 1987;13:486-92.
41. Rushton L. Further follow-up of mortality in a United Kingdom oil refinery cohort. Br J Ind Med 1993;50:549-60.
42. MacFarland HN, Ulrich CE, Holdsworth CE, et al. A chronic inhalation study with unleaded gasoline vapor. J Am Coll Toxicol 1984;1984:231-48.
43. Poole C, Dreyer NA, Satterfield MH, et al. Kidney cancer and hydrocarbon exposures among petroleum refinery workers. Environ Health Perspect 1993;101(suppl 6):53-62.
44. Wen CP. Epidemiological studies of the role of gasoline (hydrocarbon) exposure in kidney cancer risk. Adv Mod Environ Toxicol 1984;7:245-58.
45. Wong O, Harris F, Smith TJ. Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States. Environ Health Perspect 1993;101(suppl 6):63-76.
46. Gamble JF, Pearlman ED, Nicolich MJ. A nested case-control study of kidney cancer among refinery/petrochemical workers. Environ Health Perspect 1996;104:642-50.
47. Rushton L. Further follow-up of mortality in a United Kingdom oil distribution centre cohort. Br J Ind Med 1993;50:561-9.
48. Tolbert PE, Eisen EA, Pothier LJ, et al. Mortality studies of machining-fluid exposure in the automotive industry II. Risks associated with specific fluid types. Scand J Work Environ Health 1992;18:351-60.
49. Kazerouni N, Thomas TL, Petralia SA, et al. Mortality among workers exposed to cutting oil mists: update of previous reports. Am J Ind Med 2000;38:410-16.
50. Consonni D, Pesatori AC, Tironi A, et al. Mortality study in an Italian oil refinery: extension of the follow-up. Am J Ind Med 1999;35:287-94.
51. Theriault G, Provencher S. Mortality study of oil refinery workers: five-year follow-up. J Occup Med 1987;29:357-60.
52. Divine BJ, Hartman CM, Wendt JK. Update of the Texaco mortality study 1947-93: Part I. Analysis of overall patterns of mortality among refining, research, and petrochemical workers. Occup Environ Med 1999;56:167-73.
53. Thomas TL, Stewart PA, Stemhagen A, et al. Risk of astrocytic brain tumors associated with occupational chemical exposures. Scand J Work Environ Health 1987;13:417-23.
54. CONCAWE. Petroleum coke. Product Dossier No. 93/105. 1993.
55. Shottenfeld D, Fraumeni Jr JF. Cancers of the lung and pleura. In: Shottenfeld D, Fraumeni Jr JF, eds. Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996.
56. Klonne DR, Burns JM, Halder CA, et al. Two-year inhalation toxicity study of petroleum coke in rats and monkeys. Am J Ind Med 1987;11:375-89.
57. Monarca S, Pasquini R, Sforzolini GS, et al. Application of the salmonella mutagenicity assay and determination of polycyclic aromatic hydrocarbons in workplaces exposed to petroleum pitch and petroleum coke. Int Arch Occup Environ Health 1982;49:223-39.
58. American Petroleum Institute. In vivo and in vitro mutagenicity studies - delayed process coke. A revised final report. API 28-30728, 20 January, 1981.
59. American Petroleum Institute. In vivo and in vitro mutagenicity studies - fluid process coke. A revised final report. API 28-30726, 20 January 1981.
60. Divine BJ, Hartman CM, Wendt JK. An updated report on the Texaco mortality study 1947-1993. Internal report, October 1996.
61. Milby TH, Baselt RC. Hydrogen sulfide poisoning: clarification of some controversial issues. Am J Ind Med 1999;35:192-5.
62. Guidotti TL. Hydrogen sulphide. Occup Med 1996;46:367-71.
63. Guidotti TL. Occupational exposure to hydrogen sulfide in the sour gas industry: some unresolved issues. Int Arch Occup Environ Health 1994;66:153-60.
64. Hessel PA, Melenka LS. Health effects of acute hydrogen sulfide exposures in oil and gas workers. Environ Epidemiol Toxicol 1999;1:201-6.